Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Tasting America: An Excursion Through Darling Cheap Food Brands - 2Iran denies launching ballistic missiles towards Kurdistan region of Iraq
- 3UPM Adhesive Materials plans new facility near New Delhi, India
- 4Figure out How to Establish a long term connection with Your Handshake
- 5UK, Canada, Germany, others condemn Israel's West Bank settlement plan
- Figure out How to Recognize Early Indications of Depressions
- Getting through a Lifelong Change: Individual Examples of overcoming adversity
- Dominating Capable Mastercard Utilization: Key Contemplations
- High velocity Internet services for Metropolitan Regions
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- Instructions to Utilize the Towing Highlights of the Slam 1500 Productively.
- Several injured as man threatens attack on German high-speed train
- What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
